Highlight: A Potential Breakthrough in Combatting Alzheimer's
This week, the FDA fully approved a new drug meant to combat the effects of Alzheimer's disease. Whom will this ultimately benefit? Jearlyn asks Sue Parriott, CEO of the Minnesota-North Dakota chapter of the Alzheimer's Association.
Create your
podcast in
minutes
It is Free